{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T15:10:19Z","timestamp":1742569819125,"version":"3.40.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1007\/bf03226373","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T04:59:24Z","timestamp":1329973164000},"page":"209-213","source":"Crossref","is-referenced-by-count":3,"title":["Induction of hepatic and presystemic metabolism of antipyrine in the mice: Rifampicin versus rifabutin"],"prefix":"10.1007","volume":"26","author":[{"given":"Xiao G.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem K.","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"BF03226373_CR1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003088-199528020-00003","volume":"28","author":"M.H. Skinner","year":"1995","unstructured":"Skinner M.H., Blaschke T.F. (1995): Clinical pharmacokinetics of rifabutin. Clin. Pharmacokinet., 28 (2): 115\u2013125.","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl. 9","key":"BF03226373_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1289\/ehp.94102s9101","volume":"102","author":"M. Strolin-Benedetti","year":"1994","unstructured":"Strolin-Benedetti M., Dostert P. (1994): Induction and autoinduction properties of rifamycin derivatives: A review of animal and human studies. Environ. Health Perspect., 102 (Suppl. 9): 101\u2013105.","journal-title":"Environ. Health Perspect."},{"issue":"21","key":"BF03226373_CR3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.1997.00440420085007","volume":"157","author":"V.A. Strayhorn","year":"1997","unstructured":"Strayhorn V.A., Baciewicz A.M., Self T.H. (1997): Update on rifampin drug interactions, III. Arch. Intern Med., 157 (21): 2453\u20132458.","journal-title":"Arch. Intern Med."},{"issue":"4","key":"BF03226373_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1043-6618(05)80021-0","volume":"32","author":"M. Strolin-Benedetti","year":"1995","unstructured":"Strolin-Benedetti M. (1995): Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs. Pharmacol. Res., 32 (4): 177\u2013178.","journal-title":"Pharmacol. Res."},{"key":"BF03226373_CR5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/BF01733779","volume":"63","author":"U. Loos","year":"1985","unstructured":"Loos U., Musch E., Jensen J.C., Mikus G., Schwabe H.K., Eichelbaum M. (1985): Pharmacokinetics of oral and intravenous rifampin during chronic administration. Klin. Wochenschr. 63: 1205\u20131211.","journal-title":"Klin. Wochenschr."},{"issue":"3","key":"BF03226373_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1099-081X(199604)17:3<223::AID-BDD954>3.0.CO;2-S","volume":"17","author":"R.C. Li","year":"1996","unstructured":"Li R.C., Narang P.K., Poggesi I., Strolin-Benedetti M. (1996): A model based assessment of redistribution dependent elimination and bioavailability of rifabutin. Biopharm. Drug Dispos. 17 (3): 223\u2013236.","journal-title":"Biopharm. Drug Dispos."},{"issue":"5","key":"BF03226373_CR7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1179\/joc.1998.10.5.354","volume":"10","author":"J.N. Zhang","year":"1998","unstructured":"Zhang J.N., Lui X.G., Zhu M., Chiu F.C., R.C. (1998): Assessment of presystemic factors on the oral bioavailability of rifampicin following multiple dosing. J. Chemother., 10 (5): 354\u2013359.","journal-title":"J. Chemother."},{"key":"BF03226373_CR8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000137254","volume":"18","author":"M. Danhof","year":"1979","unstructured":"Danhof M., Groot-van der Vis E., Breiner D.D. (1979): Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. Pharmacology. 18: 210\u2013223.","journal-title":"Pharmacology"},{"key":"BF03226373_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"Gibaldi M., Perrier D. (1982): Noncompartmental analysis based on statistical moment theory. In: \u00abPharmacokinetics, 2nd ed\u00bb (J. Swarbrick, ed.), pp. 409\u2013416. Marcel Dekker, Inc., New York.","edition":"2nd ed"},{"key":"BF03226373_CR10","first-page":"609","volume-title":"Principles and metabolism of toxicology","author":"P.F. Guengerich","year":"1982","unstructured":"Guengerich P.F. (1982): Microsomal enzymes involved in toxicology-analysis and separation. In: \u00abPrinciples and metabolism of toxicology\u00bb (Wallace Hayes, ed.), pp. 609\u2013634. Raven Press, New York."},{"key":"BF03226373_CR11","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","volume":"239","author":"T. Omura","year":"1964","unstructured":"Omura, T. and Sato, R. (1964): The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370\u20132378.","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"BF03226373_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(99)00034-6","volume":"62","author":"L.Z. Benet","year":"1999","unstructured":"Benet L.Z., Izumi T., Zhang Y., Silverman J.A., Wacher V.J. (1999): Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J. Control Release. 62 (1\u20132): 25\u201331.","journal-title":"J. Control Release"},{"issue":"2","key":"BF03226373_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CPP38069","volume":"38","author":"M.F. Fromm","year":"2000","unstructured":"Fromm M.F. (2000): P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int. J. Clin. Pharmacol. Ther. 38 (2): 69\u201374.","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"2","key":"BF03226373_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","volume":"104","author":"B. Greiner","year":"1999","unstructured":"Greiner B., Eichebaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., Kroemer H.K. (1999): The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104 (2): 147\u2013153.","journal-title":"J. Clin. Invest."},{"issue":"4","key":"BF03226373_CR15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mcp.2000.109797","volume":"68","author":"K. Westphal","year":"2000","unstructured":"Westphal K., Weinbrenner A., Zschiesche M., Franke G., Knoke M., Oertel R., Fritz P., von Richter O., Warzok R., Hachenberg T., Kauffmann H.M., Schrenk D., Terhaag B., Kroemer H.K., Siegmund W. (2000): Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug\/drug interaction. Clin. Pharmacol. Ther. 68 (4): 345\u2013355.","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF03226373_CR16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hep.510240407","volume":"24","author":"M.F. Fromm","year":"1996","unstructured":"Fromm M.F., Busse D., Kroemer H.K., Eichelbaum M. (1996): Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology. 24: 796\u2013801.","journal-title":"Hepatology"},{"key":"BF03226373_CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/clpt.1992.171","volume":"52","author":"M.F. Hebert","year":"1992","unstructured":"Hebert M.F., Roberts J.P., Prueksaritanont T., Benet L.Z. (1992): Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin. Pharmacol. Ther. 52: 453\u20137.","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF03226373_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/00912709922007499","volume":"39","author":"M.F. Hebert","year":"1999","unstructured":"Hebert M.F., Fisher R.M., Mash C.L., Dressler D., Bekersky I. (1999): Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J. Clin. Pharmacol. 39: 91\u201396.","journal-title":"J. Clin. Pharmacol."},{"key":"BF03226373_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-9556(25)08415-6","volume":"24","author":"N. Holtbecker","year":"1996","unstructured":"Holtbecker N., Fromm M.F., Kroemer H.K., Ohnhaus E.E., Heidemann H. (1996): The nifedipine-rifampin interaction: Evidence for induction of gut wall metabolism. Drug Metab Dispos. 24: 121\u20133.","journal-title":"Drug Metab Dispos."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03226373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03226373\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03226373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T14:45:06Z","timestamp":1742568306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03226373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["BF03226373"],"URL":"https:\/\/doi.org\/10.1007\/bf03226373","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}